Paul Chaplin

Bavarian Nordic (Denmark) — Denmark

Immunology and Microbiology · Life Sciences

41h-index4.7kcitations102works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(41), Poxvirus research and outbreaks(37), Virus-based gene therapy research(24), Herpesvirus Infections and Treatments(17), vaccines and immunoinformatics approaches(16)

Publications102 total

Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine
Human Vaccines & Immunotherapeutics·2024· 8 citedOpen Access
Equivalence of Freeze-dried and Liquid-frozen Formulations of MVA-BN as Smallpox and Mpox Vaccine
2024Open Access
Abstract LB223: Intratumoral administration of modified vaccinia Ankara expressing a tumor associated antigen and the costimulatory molecules IL-12 and 4-1BBL induces potent systemic long-term immune responses against murine tumors
Cancer Research·2023
Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication
Scientific Reports·2023· 5 citedOpen Access
LB1579. A single and a two-dose regimen of MVA-BN elicit similar memory responses to a boost vaccination two years after the initial regimen, indicating potential flexibility for a delayed second dose of MVA-BN in the ongoing monkeypox emergency
Open Forum Infectious Diseases·2022· 1 citedOpen Access
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines
The Journal of Infectious Diseases·2022· 50 citedOpen Access
Single and 2-dose vaccinations with MVA-BN <sup>®</sup> induce durable B cell memory responses in healthy volunteers that are comparable to older generation replicating smallpox vaccines
2022· 1 citedOpen Access
A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection
Frontiers in Immunology·2022· 24 citedOpen Access
A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques
Frontiers in Immunology·2022· 27 citedOpen Access
Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses
The Journal of Infectious Diseases·2021· 20 citedOpen Access
Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory
Journal for ImmunoTherapy of Cancer·2021· 25 citedOpen Access
MVA-BN as monkeypox vaccine for healthy and immunocompromised
International Journal of Infectious Diseases·2020· 13 citedOpen Access
P04.02 A novel cancer immunotherapy combines rMVA-CD40L with tumor targeting antibodies
2020· 1 citedOpen Access
Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine
The Journal of Infectious Diseases·2020· 61 cited
A Modified Vaccine against Smallpox
New England Journal of Medicine·2020· 1 cited
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS
Vaccine·2020· 69 cited
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial
Vaccine·2020· 59 cited
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
New England Journal of Medicine·2019· 251 citedOpen Access
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies
Nature Communications·2019· 43 citedOpen Access
LB11. A Single Dose of the MVA-BN Smallpox Vaccine Induces an Early Protective Antibody Response Similar to a Traditional Replicating Vaccine and Is Suitable for Emergency Scenarios
Open Forum Infectious Diseases·2019Open Access
page 1 of 6Next →

Frequent Co-authors

Mark Suter(10), Darja Schmidt(8), Jürgen Hausmann(8), Jens Vollmar(7), Alfred von Krempelhuber(7), Hubertus Hochrein(6), Heinz Weidenthaler(6), Henning Lauterbach(5), Nathaly Samy(5), Garth Virgin(5), Peter McWaters(5), Jan M. Tennent(5), Jean‐Pierre Y. Scheerlinck(5), Thomas P.H. Meyer(4), Günter Silbernagl(4), Luis Mateo(4), Robert A. Collins(4), Barbara Petzold(4), Maria Tzatzaris(4), Sharon E. Frey(4)